Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
Conditions
Atopic Dermatitis (Eczema) · Atopic Dermatitis Eczema · Atopic Dermatitis · Atopic Dermatitis (AD) · Eczema · Eczema, Atopic
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Canopy Clinical Northern Beaches, Brookvale, New South Wales, Australia
Contact: Study coordinator (Dr Deon Smith) · dsmith@northernbeachesclinicalresearch.com · +61 1300 55 96 76Momentum Clinical Research, Darlinghurst, New South Wales, Australia
Contact: Study coordinator (Dr Madeleine Janin) · maddie.janin@momentumclinicalresearch.com · +61 2 8038 1044Premier Specialists, Kogarah, New South Wales, Australia
Contact: Study coordinator (Prof Dedee Murrell) · premierspectrialsprofmurrell@gmail.com · +61 2 9598 5800St George Dermatology, Kogarah, New South Wales, Australia
Novatrials, Kotara, New South Wales, Australia
Innovate Clinical Research, Waitara, New South Wales, Australia
Canopy Clinical Wollongong, Wollongong, New South Wales, Australia
Contact: Study coordinator (Dr Tess Tonkin) · ttonkin@wollongongclinicalreseach.com · +61 1300 112 708The Skin Center, Benowa, Queensland, Australia
Momentum Clinical Research, Wellers Hill, Queensland, Australia
Contact: Study coordinator (Dr Ellie Ngoh) · Ellie.Ngoh@momentumclinicalresearch.com.au · +61 7 3517 0529Veracity Clinical Research, Woolloongabba, Queensland, Australia
Canopy Clinical Altona North, North Altona, Victoria, Australia
Captain Stirling Medical Centre, Nedlands, Western Australia, Australia
Study leads
Gary Pekoe, PhD
Study Director
Alphyn Biologics